SCHEMBL32682798

SCHEMBL32682798

CC1(C)OB(c2cc(C#N)ccc2-c2ccccc2-c2nc(-c3ccccc3)nc(-c3ccccc3)n2)OC1(C)C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABCG2 Q9UNQ0 16/20 0.38
▸ ABCB1 P08183 9/20 0.38
▸ MEN1 O00255 2/20 0.37
▸ ALDH1A1 P00352 2/20 0.37
▸ CYP1A2 P05177 2/20 0.37
▸ CYP3A4 P08684 2/20 0.37
▸ CYP2C19 P33261 2/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ CLK4 Q9HAZ1 2/20 0.37
▸ LMNA P02545 1/20 0.37
▸ CYP2D6 P10635 1/20 0.37
▸ CYP2C9 P11712 1/20 0.37
▸ TSHR P16473 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.37
▸ LPL P06858 1/20 0.36
▸ LIPG Q9Y5X9 1/20 0.36
▸ ABCC1 P33527 4/20 0.35
▸ MAPK1 P28482 1/20 0.34
▸ GABRA1 P14867 1/20 0.33
▸ GABRG2 P18507 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31643430 0.92 LPL (0.39) ABCG2ABCB1LPLLIPGABCC1
SCHEMBL31643719 0.90 LPL (0.37) ABCG2ABCB1MEN1ALDH1A1CYP1A2
SCHEMBL31643730 0.85 LPL (0.37) ABCG2ABCB1MEN1ALDH1A1CYP1A2
SCHEMBL32682794 0.85 LPL (0.40) ABCG2ABCB1LPLLIPGABCC1
SCHEMBL31643544 0.83 TNKS (0.34) ABCG2ABCB1MEN1ALDH1A1CYP1A2
SCHEMBL31643057 0.82 LIPG (0.46) ABCG2ABCB1LPLLIPGABCC1
SCHEMBL31643748 0.81 LPL (0.39) ABCG2ABCB1MEN1ALDH1A1CYP1A2
SCHEMBL31642621 0.79 LIPG (0.50) ABCG2ABCB1LPLLIPGABCC1
SCHEMBL25775483 0.79 ABCG2 (0.50) ABCG2ABCB1MEN1ALDH1A1CYP1A2
SCHEMBL26553114 0.79 ABCG2 (0.50) ABCG2ABCB1MEN1ALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260076091-A1 LIGHT-EMITTING DEVICE INCLUDING HETEROCYCLIC COMPOUND, ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE, AND THE HETEROCYCLIC COMPOUND SAMSUNG DISPLAY CO., LTD. (KR) 2026-03-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260076091-A1 LIGHT-EMITTING DEVICE INCLUDING HETEROCYCLIC COMPOUND, ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE, AND THE HETEROCYCLIC COMPOUND CRY1, CHRM1, H1-0 ABCG2 4568/4885ABCB1 4655/4885MEN1 287/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback